Tag: generic drug surveillance
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs
Dec, 29 2025
OTC Cold Medications and Warfarin: What You Must Avoid to Stay Safe
Mar, 12 2026
Are Generic Medications Safe? Common Questions and Facts Explained
Apr, 6 2026
Why Lupus Support Groups Matter for Discoid and Systemic Lupus Patients
Oct, 17 2025
Closed-Loop Systems: Automated Insulin Delivery and Real-World Results
May, 7 2026